Low rate of lymphedema after extended pelvic lymphadenectomy followed by pelvic irradiation of node-positive prostate cancer
Identifieur interne : 003491 ( Main/Exploration ); précédent : 003490; suivant : 003492Low rate of lymphedema after extended pelvic lymphadenectomy followed by pelvic irradiation of node-positive prostate cancer
Auteurs : Elisabeth Rasmusson [Suède] ; Adalsteinn Gunnlaugsson [Suède] ; René Blom [Suède] ; Thomas Björk-Eriksson [Suède] ; Per Nilsson [Suède] ; Göran Ahlgen [Suède] ; Charlotta Jönsson [Suède] ; Karin Johansson [Suède] ; Elisabeth Kjellén [Suède]Source :
- Radiation Oncology (London, England) [ 1748-717X ] ; 2013.
Descripteurs français
- KwdFr :
- Adulte d'âge moyen, Bas de contention, Curiethérapie (), Curiethérapie (effets indésirables), Dosimétrie en radiothérapie, Facteurs temps, Humains, Lymphadénectomie (effets indésirables), Lymphoedème (anatomopathologie), Lésions radio-induites (étiologie), Mâle, Métastase lymphatique (radiothérapie), Noeuds lymphatiques (anatomopathologie), Prévalence, Radiothérapie (), Radiothérapie (effets indésirables), Résultat thérapeutique, Sujet âgé, Tumeurs de la prostate (), Tumeurs de la prostate (radiothérapie), Études de suivi, Études rétrospectives.
- MESH :
- anatomopathologie : Lymphoedème, Noeuds lymphatiques.
- effets indésirables : Curiethérapie, Lymphadénectomie, Radiothérapie.
- radiothérapie : Métastase lymphatique, Tumeurs de la prostate.
- étiologie : Lésions radio-induites.
- Adulte d'âge moyen, Bas de contention, Curiethérapie, Dosimétrie en radiothérapie, Facteurs temps, Humains, Mâle, Prévalence, Radiothérapie, Résultat thérapeutique, Sujet âgé, Tumeurs de la prostate, Études de suivi, Études rétrospectives.
English descriptors
- KwdEn :
- Aged, Brachytherapy (adverse effects), Brachytherapy (methods), Follow-Up Studies, Humans, Lymph Node Excision (adverse effects), Lymph Nodes (pathology), Lymphatic Metastasis (radiotherapy), Lymphedema (pathology), Male, Middle Aged, Prevalence, Prostatic Neoplasms (complications), Prostatic Neoplasms (radiotherapy), Radiation Injuries (etiology), Radiotherapy (adverse effects), Radiotherapy (methods), Radiotherapy Dosage, Retrospective Studies, Stockings, Compression, Time Factors, Treatment Outcome.
- MESH :
- adverse effects : Brachytherapy, Lymph Node Excision, Radiotherapy.
- complications : Prostatic Neoplasms.
- etiology : Radiation Injuries.
- methods : Brachytherapy, Radiotherapy.
- pathology : Lymph Nodes, Lymphedema.
- radiotherapy : Lymphatic Metastasis, Prostatic Neoplasms.
- Aged, Follow-Up Studies, Humans, Male, Middle Aged, Prevalence, Radiotherapy Dosage, Retrospective Studies, Stockings, Compression, Time Factors, Treatment Outcome.
Abstract
The aim of the present study was to evaluate the prevalence and severity of lower limb lymphedema after pelvic lymphadenectomy and radiotherapy to the pelvic lymph nodes in patients with prostate cancer.
Twenty-six patients underwent combined treatment for high-risk node-positive prostate cancer at Skåne University Hospital between April 2008 and March 2011. The treatment consisted of extended pelvic lymphadenectomy followed by androgen deprivation therapy and radiotherapy. The pelvic lymphnodes, prostate and seminal vesicles were treated with external beam radiotherapy (EBRT) to an absorbed dose of 50 Gy followed by a brachytherapy (BT) boost of 2x10 Gy to the prostate only. Twenty-two patients accepted an invitation to a clinical examination with focus on lower limb swelling. The median time between the end of radiotherapy and examination was 2.2 years (range 1.2–4.1).
Six patients (27%) experienced grade 1 lymphedema and two patients (9%) grade 2 while none had grade 3 or 4 according to the CTC Common Toxicity Criteria scale 4.0. Three patients required treatment with compression stockings.
Brachytherapy and pelvic EBRT have a low incidence of lymphedema (at median 2.2 y after treatment) in patients with high-risk node-positive prostate cancer that have undergone pelvic lymph node dissection.
Url:
DOI: 10.1186/1748-717X-8-271
PubMed: 24252686
PubMed Central: 3842657
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: 002B35
- to stream Pmc, to step Curation: 002B34
- to stream Pmc, to step Checkpoint: 002217
- to stream PubMed, to step Corpus: 001825
- to stream PubMed, to step Curation: 001825
- to stream PubMed, to step Checkpoint: 001825
- to stream Ncbi, to step Merge: 005F63
- to stream Ncbi, to step Curation: 005F63
- to stream Ncbi, to step Checkpoint: 005F63
- to stream Main, to step Merge: 003497
- to stream Main, to step Curation: 003491
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Low rate of lymphedema after extended pelvic lymphadenectomy followed by pelvic irradiation of node-positive prostate cancer</title><author><name sortKey="Rasmusson, Elisabeth" sort="Rasmusson, Elisabeth" uniqKey="Rasmusson E" first="Elisabeth" last="Rasmusson">Elisabeth Rasmusson</name><affiliation wicri:level="1"><nlm:aff id="I1">Department of Oncology, Skåne University Hospital, SE-205 02 Malmö, Sweden</nlm:aff><country xml:lang="fr">Suède</country><wicri:regionArea>Department of Oncology, Skåne University Hospital, SE-205 02 Malmö</wicri:regionArea><wicri:noRegion>SE-205 02 Malmö</wicri:noRegion></affiliation></author><author><name sortKey="Gunnlaugsson, Adalsteinn" sort="Gunnlaugsson, Adalsteinn" uniqKey="Gunnlaugsson A" first="Adalsteinn" last="Gunnlaugsson">Adalsteinn Gunnlaugsson</name><affiliation wicri:level="1"><nlm:aff id="I1">Department of Oncology, Skåne University Hospital, SE-205 02 Malmö, Sweden</nlm:aff><country xml:lang="fr">Suède</country><wicri:regionArea>Department of Oncology, Skåne University Hospital, SE-205 02 Malmö</wicri:regionArea><wicri:noRegion>SE-205 02 Malmö</wicri:noRegion></affiliation></author><author><name sortKey="Blom, Rene" sort="Blom, Rene" uniqKey="Blom R" first="René" last="Blom">René Blom</name><affiliation wicri:level="1"><nlm:aff id="I1">Department of Oncology, Skåne University Hospital, SE-205 02 Malmö, Sweden</nlm:aff><country xml:lang="fr">Suède</country><wicri:regionArea>Department of Oncology, Skåne University Hospital, SE-205 02 Malmö</wicri:regionArea><wicri:noRegion>SE-205 02 Malmö</wicri:noRegion></affiliation></author><author><name sortKey="Bjork Eriksson, Thomas" sort="Bjork Eriksson, Thomas" uniqKey="Bjork Eriksson T" first="Thomas" last="Björk-Eriksson">Thomas Björk-Eriksson</name><affiliation wicri:level="1"><nlm:aff id="I2">Department of Oncology, Sahlgrenska University Hospital, SE-413 45 Gothenburg, Sweden</nlm:aff><country xml:lang="fr">Suède</country><wicri:regionArea>Department of Oncology, Sahlgrenska University Hospital, SE-413 45 Gothenburg</wicri:regionArea><wicri:noRegion>SE-413 45 Gothenburg</wicri:noRegion></affiliation></author><author><name sortKey="Nilsson, Per" sort="Nilsson, Per" uniqKey="Nilsson P" first="Per" last="Nilsson">Per Nilsson</name><affiliation wicri:level="1"><nlm:aff id="I1">Department of Oncology, Skåne University Hospital, SE-205 02 Malmö, Sweden</nlm:aff><country xml:lang="fr">Suède</country><wicri:regionArea>Department of Oncology, Skåne University Hospital, SE-205 02 Malmö</wicri:regionArea><wicri:noRegion>SE-205 02 Malmö</wicri:noRegion></affiliation></author><author><name sortKey="Ahlgen, Goran" sort="Ahlgen, Goran" uniqKey="Ahlgen G" first="Göran" last="Ahlgen">Göran Ahlgen</name><affiliation wicri:level="1"><nlm:aff id="I3">Department of Urology, Skåne University Hospital, SE-205 02 Malmö, Sweden</nlm:aff><country xml:lang="fr">Suède</country><wicri:regionArea>Department of Urology, Skåne University Hospital, SE-205 02 Malmö</wicri:regionArea><wicri:noRegion>SE-205 02 Malmö</wicri:noRegion></affiliation></author><author><name sortKey="Jonsson, Charlotta" sort="Jonsson, Charlotta" uniqKey="Jonsson C" first="Charlotta" last="Jönsson">Charlotta Jönsson</name><affiliation wicri:level="1"><nlm:aff id="I1">Department of Oncology, Skåne University Hospital, SE-205 02 Malmö, Sweden</nlm:aff><country xml:lang="fr">Suède</country><wicri:regionArea>Department of Oncology, Skåne University Hospital, SE-205 02 Malmö</wicri:regionArea><wicri:noRegion>SE-205 02 Malmö</wicri:noRegion></affiliation></author><author><name sortKey="Johansson, Karin" sort="Johansson, Karin" uniqKey="Johansson K" first="Karin" last="Johansson">Karin Johansson</name><affiliation wicri:level="1"><nlm:aff id="I1">Department of Oncology, Skåne University Hospital, SE-205 02 Malmö, Sweden</nlm:aff><country xml:lang="fr">Suède</country><wicri:regionArea>Department of Oncology, Skåne University Hospital, SE-205 02 Malmö</wicri:regionArea><wicri:noRegion>SE-205 02 Malmö</wicri:noRegion></affiliation></author><author><name sortKey="Kjellen, Elisabeth" sort="Kjellen, Elisabeth" uniqKey="Kjellen E" first="Elisabeth" last="Kjellén">Elisabeth Kjellén</name><affiliation wicri:level="1"><nlm:aff id="I1">Department of Oncology, Skåne University Hospital, SE-205 02 Malmö, Sweden</nlm:aff><country xml:lang="fr">Suède</country><wicri:regionArea>Department of Oncology, Skåne University Hospital, SE-205 02 Malmö</wicri:regionArea><wicri:noRegion>SE-205 02 Malmö</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">24252686</idno><idno type="pmc">3842657</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3842657</idno><idno type="RBID">PMC:3842657</idno><idno type="doi">10.1186/1748-717X-8-271</idno><date when="2013">2013</date><idno type="wicri:Area/Pmc/Corpus">002B35</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">002B35</idno><idno type="wicri:Area/Pmc/Curation">002B34</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">002B34</idno><idno type="wicri:Area/Pmc/Checkpoint">002217</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">002217</idno><idno type="wicri:source">PubMed</idno><idno type="wicri:Area/PubMed/Corpus">001825</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001825</idno><idno type="wicri:Area/PubMed/Curation">001825</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001825</idno><idno type="wicri:Area/PubMed/Checkpoint">001825</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001825</idno><idno type="wicri:Area/Ncbi/Merge">005F63</idno><idno type="wicri:Area/Ncbi/Curation">005F63</idno><idno type="wicri:Area/Ncbi/Checkpoint">005F63</idno><idno type="wicri:Area/Main/Merge">003497</idno><idno type="wicri:Area/Main/Curation">003491</idno><idno type="wicri:Area/Main/Exploration">003491</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Low rate of lymphedema after extended pelvic lymphadenectomy followed by pelvic irradiation of node-positive prostate cancer</title><author><name sortKey="Rasmusson, Elisabeth" sort="Rasmusson, Elisabeth" uniqKey="Rasmusson E" first="Elisabeth" last="Rasmusson">Elisabeth Rasmusson</name><affiliation wicri:level="1"><nlm:aff id="I1">Department of Oncology, Skåne University Hospital, SE-205 02 Malmö, Sweden</nlm:aff><country xml:lang="fr">Suède</country><wicri:regionArea>Department of Oncology, Skåne University Hospital, SE-205 02 Malmö</wicri:regionArea><wicri:noRegion>SE-205 02 Malmö</wicri:noRegion></affiliation></author><author><name sortKey="Gunnlaugsson, Adalsteinn" sort="Gunnlaugsson, Adalsteinn" uniqKey="Gunnlaugsson A" first="Adalsteinn" last="Gunnlaugsson">Adalsteinn Gunnlaugsson</name><affiliation wicri:level="1"><nlm:aff id="I1">Department of Oncology, Skåne University Hospital, SE-205 02 Malmö, Sweden</nlm:aff><country xml:lang="fr">Suède</country><wicri:regionArea>Department of Oncology, Skåne University Hospital, SE-205 02 Malmö</wicri:regionArea><wicri:noRegion>SE-205 02 Malmö</wicri:noRegion></affiliation></author><author><name sortKey="Blom, Rene" sort="Blom, Rene" uniqKey="Blom R" first="René" last="Blom">René Blom</name><affiliation wicri:level="1"><nlm:aff id="I1">Department of Oncology, Skåne University Hospital, SE-205 02 Malmö, Sweden</nlm:aff><country xml:lang="fr">Suède</country><wicri:regionArea>Department of Oncology, Skåne University Hospital, SE-205 02 Malmö</wicri:regionArea><wicri:noRegion>SE-205 02 Malmö</wicri:noRegion></affiliation></author><author><name sortKey="Bjork Eriksson, Thomas" sort="Bjork Eriksson, Thomas" uniqKey="Bjork Eriksson T" first="Thomas" last="Björk-Eriksson">Thomas Björk-Eriksson</name><affiliation wicri:level="1"><nlm:aff id="I2">Department of Oncology, Sahlgrenska University Hospital, SE-413 45 Gothenburg, Sweden</nlm:aff><country xml:lang="fr">Suède</country><wicri:regionArea>Department of Oncology, Sahlgrenska University Hospital, SE-413 45 Gothenburg</wicri:regionArea><wicri:noRegion>SE-413 45 Gothenburg</wicri:noRegion></affiliation></author><author><name sortKey="Nilsson, Per" sort="Nilsson, Per" uniqKey="Nilsson P" first="Per" last="Nilsson">Per Nilsson</name><affiliation wicri:level="1"><nlm:aff id="I1">Department of Oncology, Skåne University Hospital, SE-205 02 Malmö, Sweden</nlm:aff><country xml:lang="fr">Suède</country><wicri:regionArea>Department of Oncology, Skåne University Hospital, SE-205 02 Malmö</wicri:regionArea><wicri:noRegion>SE-205 02 Malmö</wicri:noRegion></affiliation></author><author><name sortKey="Ahlgen, Goran" sort="Ahlgen, Goran" uniqKey="Ahlgen G" first="Göran" last="Ahlgen">Göran Ahlgen</name><affiliation wicri:level="1"><nlm:aff id="I3">Department of Urology, Skåne University Hospital, SE-205 02 Malmö, Sweden</nlm:aff><country xml:lang="fr">Suède</country><wicri:regionArea>Department of Urology, Skåne University Hospital, SE-205 02 Malmö</wicri:regionArea><wicri:noRegion>SE-205 02 Malmö</wicri:noRegion></affiliation></author><author><name sortKey="Jonsson, Charlotta" sort="Jonsson, Charlotta" uniqKey="Jonsson C" first="Charlotta" last="Jönsson">Charlotta Jönsson</name><affiliation wicri:level="1"><nlm:aff id="I1">Department of Oncology, Skåne University Hospital, SE-205 02 Malmö, Sweden</nlm:aff><country xml:lang="fr">Suède</country><wicri:regionArea>Department of Oncology, Skåne University Hospital, SE-205 02 Malmö</wicri:regionArea><wicri:noRegion>SE-205 02 Malmö</wicri:noRegion></affiliation></author><author><name sortKey="Johansson, Karin" sort="Johansson, Karin" uniqKey="Johansson K" first="Karin" last="Johansson">Karin Johansson</name><affiliation wicri:level="1"><nlm:aff id="I1">Department of Oncology, Skåne University Hospital, SE-205 02 Malmö, Sweden</nlm:aff><country xml:lang="fr">Suède</country><wicri:regionArea>Department of Oncology, Skåne University Hospital, SE-205 02 Malmö</wicri:regionArea><wicri:noRegion>SE-205 02 Malmö</wicri:noRegion></affiliation></author><author><name sortKey="Kjellen, Elisabeth" sort="Kjellen, Elisabeth" uniqKey="Kjellen E" first="Elisabeth" last="Kjellén">Elisabeth Kjellén</name><affiliation wicri:level="1"><nlm:aff id="I1">Department of Oncology, Skåne University Hospital, SE-205 02 Malmö, Sweden</nlm:aff><country xml:lang="fr">Suède</country><wicri:regionArea>Department of Oncology, Skåne University Hospital, SE-205 02 Malmö</wicri:regionArea><wicri:noRegion>SE-205 02 Malmö</wicri:noRegion></affiliation></author></analytic><series><title level="j">Radiation Oncology (London, England)</title><idno type="eISSN">1748-717X</idno><imprint><date when="2013">2013</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term><term>Brachytherapy (adverse effects)</term><term>Brachytherapy (methods)</term><term>Follow-Up Studies</term><term>Humans</term><term>Lymph Node Excision (adverse effects)</term><term>Lymph Nodes (pathology)</term><term>Lymphatic Metastasis (radiotherapy)</term><term>Lymphedema (pathology)</term><term>Male</term><term>Middle Aged</term><term>Prevalence</term><term>Prostatic Neoplasms (complications)</term><term>Prostatic Neoplasms (radiotherapy)</term><term>Radiation Injuries (etiology)</term><term>Radiotherapy (adverse effects)</term><term>Radiotherapy (methods)</term><term>Radiotherapy Dosage</term><term>Retrospective Studies</term><term>Stockings, Compression</term><term>Time Factors</term><term>Treatment Outcome</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Bas de contention</term><term>Curiethérapie ()</term><term>Curiethérapie (effets indésirables)</term><term>Dosimétrie en radiothérapie</term><term>Facteurs temps</term><term>Humains</term><term>Lymphadénectomie (effets indésirables)</term><term>Lymphoedème (anatomopathologie)</term><term>Lésions radio-induites (étiologie)</term><term>Mâle</term><term>Métastase lymphatique (radiothérapie)</term><term>Noeuds lymphatiques (anatomopathologie)</term><term>Prévalence</term><term>Radiothérapie ()</term><term>Radiothérapie (effets indésirables)</term><term>Résultat thérapeutique</term><term>Sujet âgé</term><term>Tumeurs de la prostate ()</term><term>Tumeurs de la prostate (radiothérapie)</term><term>Études de suivi</term><term>Études rétrospectives</term></keywords><keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Brachytherapy</term><term>Lymph Node Excision</term><term>Radiotherapy</term></keywords><keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Lymphoedème</term><term>Noeuds lymphatiques</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Prostatic Neoplasms</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Curiethérapie</term><term>Lymphadénectomie</term><term>Radiothérapie</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Radiation Injuries</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Brachytherapy</term><term>Radiotherapy</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Lymph Nodes</term><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="radiotherapy" xml:lang="en"><term>Lymphatic Metastasis</term><term>Prostatic Neoplasms</term></keywords><keywords scheme="MESH" qualifier="radiothérapie" xml:lang="fr"><term>Métastase lymphatique</term><term>Tumeurs de la prostate</term></keywords><keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Lésions radio-induites</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Follow-Up Studies</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Prevalence</term><term>Radiotherapy Dosage</term><term>Retrospective Studies</term><term>Stockings, Compression</term><term>Time Factors</term><term>Treatment Outcome</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Bas de contention</term><term>Curiethérapie</term><term>Dosimétrie en radiothérapie</term><term>Facteurs temps</term><term>Humains</term><term>Mâle</term><term>Prévalence</term><term>Radiothérapie</term><term>Résultat thérapeutique</term><term>Sujet âgé</term><term>Tumeurs de la prostate</term><term>Études de suivi</term><term>Études rétrospectives</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><sec><title>Background</title><p>The aim of the present study was to evaluate the prevalence and severity of lower limb lymphedema after pelvic lymphadenectomy and radiotherapy to the pelvic lymph nodes in patients with prostate cancer.</p></sec><sec><title>Methods</title><p>Twenty-six patients underwent combined treatment for high-risk node-positive prostate cancer at Skåne University Hospital between April 2008 and March 2011. The treatment consisted of extended pelvic lymphadenectomy followed by androgen deprivation therapy and radiotherapy. The pelvic lymphnodes, prostate and seminal vesicles were treated with external beam radiotherapy (EBRT) to an absorbed dose of 50 Gy followed by a brachytherapy (BT) boost of 2x10 Gy to the prostate only. Twenty-two patients accepted an invitation to a clinical examination with focus on lower limb swelling. The median time between the end of radiotherapy and examination was 2.2 years (range 1.2–4.1).</p></sec><sec><title>Results</title><p>Six patients (27%) experienced grade 1 lymphedema and two patients (9%) grade 2 while none had grade 3 or 4 according to the CTC Common Toxicity Criteria scale 4.0. Three patients required treatment with compression stockings.</p></sec><sec><title>Conclusion</title><p>Brachytherapy and pelvic EBRT have a low incidence of lymphedema (at median 2.2 y after treatment) in patients with high-risk node-positive prostate cancer that have undergone pelvic lymph node dissection.</p></sec></div></front><back><div1 type="bibliography"><listBibl><biblStruct><analytic><author><name sortKey="Keegan, Ka" uniqKey="Keegan K">KA Keegan</name></author><author><name sortKey="Cookson, Ms" uniqKey="Cookson M">MS Cookson</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Pilepich, Mv" uniqKey="Pilepich M">MV Pilepich</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Beesley, V" uniqKey="Beesley V">V Beesley</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Bergmark, K" uniqKey="Bergmark K">K Bergmark</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Achouri, A" uniqKey="Achouri A">A Achouri</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Ryan, M" uniqKey="Ryan M">M Ryan</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Ladjevardi, S" uniqKey="Ladjevardi S">S Ladjevardi</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Akre, O" uniqKey="Akre O">O Akre</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Daneshmand, S" uniqKey="Daneshmand S">S Daneshmand</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Engel, J" uniqKey="Engel J">J Engel</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Briganti, A" uniqKey="Briganti A">A Briganti</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Briganti, A" uniqKey="Briganti A">A Briganti</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Sabolch, A" uniqKey="Sabolch A">A Sabolch</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Galalae, Rm" uniqKey="Galalae R">RM Galalae</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Pistis, F" uniqKey="Pistis F">F Pistis</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Koukourakis, G" uniqKey="Koukourakis G">G Koukourakis</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Phan, Tp" uniqKey="Phan T">TP Phan</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Hoskin, Pj" uniqKey="Hoskin P">PJ Hoskin</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Hoskin, Pj" uniqKey="Hoskin P">PJ Hoskin</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Bittner, N" uniqKey="Bittner N">N Bittner</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Heidenreich, A" uniqKey="Heidenreich A">A Heidenreich</name></author><author><name sortKey="Ohlmann, Ch" uniqKey="Ohlmann C">CH Ohlmann</name></author><author><name sortKey="Polyakov, S" uniqKey="Polyakov S">S Polyakov</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Sander, Ap" uniqKey="Sander A">AP Sander</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Nuutinen, J" uniqKey="Nuutinen J">J Nuutinen</name></author><author><name sortKey="Ikaheimo, R" uniqKey="Ikaheimo R">R Ikaheimo</name></author><author><name sortKey="Lahtinen, T" uniqKey="Lahtinen T">T Lahtinen</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Warde, P" uniqKey="Warde P">P Warde</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Marks, Lb" uniqKey="Marks L">LB Marks</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Bentzen, Sm" uniqKey="Bentzen S">SM Bentzen</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Salomon, G" uniqKey="Salomon G">G Salomon</name></author></analytic></biblStruct></listBibl></div1></back></TEI><affiliations><list><country><li>Suède</li></country></list><tree><country name="Suède"><noRegion><name sortKey="Rasmusson, Elisabeth" sort="Rasmusson, Elisabeth" uniqKey="Rasmusson E" first="Elisabeth" last="Rasmusson">Elisabeth Rasmusson</name></noRegion><name sortKey="Ahlgen, Goran" sort="Ahlgen, Goran" uniqKey="Ahlgen G" first="Göran" last="Ahlgen">Göran Ahlgen</name><name sortKey="Bjork Eriksson, Thomas" sort="Bjork Eriksson, Thomas" uniqKey="Bjork Eriksson T" first="Thomas" last="Björk-Eriksson">Thomas Björk-Eriksson</name><name sortKey="Blom, Rene" sort="Blom, Rene" uniqKey="Blom R" first="René" last="Blom">René Blom</name><name sortKey="Gunnlaugsson, Adalsteinn" sort="Gunnlaugsson, Adalsteinn" uniqKey="Gunnlaugsson A" first="Adalsteinn" last="Gunnlaugsson">Adalsteinn Gunnlaugsson</name><name sortKey="Johansson, Karin" sort="Johansson, Karin" uniqKey="Johansson K" first="Karin" last="Johansson">Karin Johansson</name><name sortKey="Jonsson, Charlotta" sort="Jonsson, Charlotta" uniqKey="Jonsson C" first="Charlotta" last="Jönsson">Charlotta Jönsson</name><name sortKey="Kjellen, Elisabeth" sort="Kjellen, Elisabeth" uniqKey="Kjellen E" first="Elisabeth" last="Kjellén">Elisabeth Kjellén</name><name sortKey="Nilsson, Per" sort="Nilsson, Per" uniqKey="Nilsson P" first="Per" last="Nilsson">Per Nilsson</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003491 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003491 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= PMC:3842657
|texte= Low rate of lymphedema after extended pelvic lymphadenectomy followed by pelvic irradiation of node-positive prostate cancer
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:24252686" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |